Cytokinetics reported $-80550000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Bayer BAYN:GR 2.02B 1.49B
Capricor Therapeutics CAPR:US $ -7.83M 1.45M
Cytokinetics CYTK:US $ -80.55M 58.85M
Eisai 4523:JP Y 13648M 8149M
Genocea Biosciences GNCA:US $ -15.77M 118.33M
Geron GERN:US $ -28.68M 2.31M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Novartis NOVN:VX 2.56B 671M